查看购物车
  • Traditional Chinese
  • English
南美洲和中美洲生物分析测试服务市场预测至 2030 年 - 区域分析 - 按服务分类；疾病适应症；和最终用户
市场调查报告书
商品编码
1463671

南美洲和中美洲生物分析测试服务市场预测至 2030 年 - 区域分析 - 按服务分类；疾病适应症；和最终用户

South & Central America Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services ; Disease Indication ; and End User
出版日期: | 出版商: The Insight Partners | 英文 100 Pages | 订单完成后即时交付

价格

2022年南美洲和中美洲生物分析测试服务市值为2.4243亿美元，预计到2030年将达到4.9176亿美元；预计 2022 年至 2030 年CAGR为 9.2%。

製药业的不间断成长推动了南美洲和中美洲生物分析测试服务市场

药品及其他医药产品的研发、生产及销售是医药工业的主要领域。随着治疗年龄相关疾病和慢性病的药物需求不断增加，全球药品消费量不断增加。根据世界卫生组织预测，从2020年到2050年，60岁或以上的老年人口预计将增加一倍，到2050年将达到约21亿。疾病、癌症、高血压、骨关节炎和糖尿病。因此，慢性病一直是製药公司关注的主要领域。新药开发是一个资源、成本和时间密集的过程，后期的临床阶段会导致巨大的成本。多家製药公司选择生物分析测试服务来进行药物开发以及临床和临床前阶段的检测验证。仿製药和品牌药物化合物大多是小分子。仿製药製造商进行并提交生物分析测试结果，以克服专利到期的问题。因此，随着製药业的不断发展，生物分析检测服务提供者未来的服务需求可能会持续成长，这将为生物分析检测服务市场带来新的成长机会。

南美洲和中美洲生物分析测试服务市场概述

南美洲和中美洲的生物分析测试服务市场细分为巴西、阿根廷以及南美洲和中美洲的其他地区。该地区的市场成长主要归功于全球製药公司在该地区建立业务的持续努力，以及各国对疾病意识的增强和医疗保健支出的增加。

南美洲和中美洲生物分析测试服务市场收入及 2030 年预测（百万美元）

南美洲和中美洲生物分析测试服务市场细分

南美洲和中美洲生物分析测试服务市场根据测试类型、疾病适应症、最终用户和国家进行细分。

根据测试类型，南美洲和中美洲生物分析测试服务市场分为药物动力学、生物标记、免疫原性、病毒学测试、基于细胞的测定等。 2022 年，基于细胞的检测领域占据最大的市场份额。

根据疾病指示，南美洲和中美洲生物分析测试服务市场分为心血管、神经系统疾病、代谢紊乱、呼吸系统疾病、自体免疫疾病、肿瘤、性健康、骨骼疾病等。 2022 年，肿瘤学领域占据最大的市场。

根据最终用户，南美洲和中美洲生物分析测试服务市场分为製药和生物製药公司、合约研究组织（CRO）、合约开发和製造组织（CDMO）等。 2022 年，製药和生物製药公司领域占据最大的市场份额。

根据国家/地区，南美洲和中美洲生物分析测试服务市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，巴西在南美洲和中美洲生物分析测试服务市场份额中占据主导地位。

SGS SA、康龙化成北京有限公司、Element Materials Technology Group Ltd、Charles River Laboratories International Inc、Eurofins Scientific SE、Labcorp Drug Development Inc、Syneos Health Inc、ICON Plc 和 Intertek Group Plc 是在南方运营的一些领先公司＆中美洲生物分析测试服务市场。

目录

表中的内容

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲生物分析测试服务市场格局

  • 概述
  • PEST分析
    • 南美洲和中美洲 PEST 分析

第 5 章：南美洲和中美洲生物分析测试服务市场 - 主要产业动态

  • 主要市场驱动因素：
    • 药厂增加研发活动外包
    • 对生物相似药和生物製剂分析测试的高需求
  • 主要市场限制：
    • 与生物分析测试服务相关的高成本
  • 主要市场机会
    • 医药产业持续成长
  • 未来的趋势
    • 针对新兴罕见疾病的药物发现和开发活动不断增加
  • 影响分析：

第 6 章：生物分析测试服务市场 - 南美洲和中美洲市场分析

  • 生物分析测试服务市场收入，2022 - 2030

第 7 章：南美洲和中美洲生物分析测试服务市场 - 收入和 2030 年预测 - 按服务

  • 概述
  • 2022 年和 2030 年生物分析测试服务市场收入份额（按服务划分）（%）
  • 药物动力学
  • 生物标誌物
  • 免疫原性
  • 病毒学检测
  • 基于细胞的检测
  • 其他的

第 8 章：南美洲和中美洲生物分析测试服务市场 - 收入和 2030 年预测 - 按疾病指示

  • 概述
  • 2022 年和 2030 年按疾病适应症分類的生物分析测试服务市场收入份额 (%)
  • 心血管
  • 神经系统疾病
  • 代谢紊乱
  • 肿瘤学
  • 性健康
  • 骨病
  • 其他的

第 9 章：南美洲和中美洲生物分析测试服务市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年生物分析测试服务市场收入份额（按最终用户划分）（%）
  • 製药和生物製药公司
  • 合约研究组织（CRO）
  • 合约开发与製造组织 (CDMO)
  • 其他的

第 10 章：南美洲和中美洲生物分析测试服务市场 - 国家分析

  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区

第 11 章：生物分析测试服务市场产业格局

  • 概述
  • 生物分析测试服务市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • SGS SA
  • Pharmaron Beijing Co Ltd
  • Element Materials Technology Group Ltd
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Labcorp Drug Development Inc
  • Syneos Health Inc
  • ICON Plc
  • Intertek Group Plc

第 13 章：附录

Product Code: BMIRE00029566

The South & Central America bioanalytical testing services market was valued at US$ 242.43 million in 2022 and is expected to reach US$ 491.76 million by 2030; it is estimated to grow at a CAGR of 9.2% from 2022 to 2030.

Uninterrupted Growth of Pharmaceuticals Industry Fuel the South & Central America Bioanalytical Testing Services Market

The research & development, production, and distribution of medicinal drugs and other pharmaceutical products are the major areas of the pharmaceutical industry. Global pharmaceutical consumption is rising with the increasing need for drugs to treat age-related diseases and chronic diseases. According to the WHO, the elderly population aged 60 or above is projected to double from 2020 to 2050, reaching ~2.1 billion by 2050. A rise in the geriatric population would contribute to a surge in incidences of chronic diseases, such as cardiovascular diseases, cancer, hypertension, osteoarthritis, and diabetes mellitus. Thus, chronic diseases have been a major area of focus for pharmaceutical companies. New drug development is a resource-, cost-, and time-intensive process, where later clinical stages result in significant costs. Several pharmaceutical companies are opting for bioanalytical testing services for drug development and validation of assays in both clinical and preclinical stages. Generics and branded drug compounds are mostly small molecules. Generics manufacturers conduct and submit bioanalytical testing results to overcome the issue of patent expiration. Thus, with the uninterrupted proliferation of the pharmaceutical industry, bioanalytical testing service providers are likely to experience a continuous rise in demand for their services in the future, which would lead to new growth opportunity in the bioanalytical testing services market.

South & Central America Bioanalytical Testing Services Market Overview

The bioanalytical testing services market in South & Central America is sub segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is primarily attributed to the ongoing efforts of global pharmaceutical companies to establish their presence in the region, along with the increasing awareness about diseases and rising healthcare expenditure by countries.

South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Bioanalytical Testing Services Market Segmentation

The South & Central America bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.

Based on test type, the South & Central America bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.

Based on disease indication, the South & Central America bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.

Based on end user, the South & Central America bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.

Based on country, the South & Central America bioanalytical testing services market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bioanalytical testing services market share in 2022.

SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the South & Central America bioanalytical testing services market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Bioanalytical Testing Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 South & Central America PEST Analysis

5. South & Central America Bioanalytical Testing Services Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
    • 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
  • 5.2 Key Market Restraints:
    • 5.2.1 High Cost Associated to Bioanalytical Testing Services
  • 5.3 Key Market Opportunities
    • 5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
  • 5.4 Future Trends
    • 5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
  • 5.5 Impact Analysis:

6. Bioanalytical Testing Services Market - South & Central America Market Analysis

  • 6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services

  • 7.1 Overview
  • 7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • 7.3 Pharmacokinetics
    • 7.3.1 Overview
    • 7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Biomarkers
    • 7.4.1 Overview
    • 7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunogenicity
    • 7.5.1 Overview
    • 7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Virology Testing
    • 7.6.1 Overview
    • 7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.1 In-Vitro Virology Testing
        • 7.6.2.1.1 Overview
      • 7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.6.3 In-Vivo Virology Testing
      • 7.6.3.1 Overview
      • 7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Cell-Based Assays
    • 7.7.1 Overview
    • 7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication

  • 8.1 Overview
  • 8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • 8.3 Cardiovascular
    • 8.3.1 Overview
    • 8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Neurological Diseases
    • 8.4.1 Overview
    • 8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Metabolic Disorders
    • 8.5.1 Overview
    • 8.5.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Oncology
    • 8.6.1 Overview
    • 8.6.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Sexual Health
    • 8.7.1 Overview
    • 8.7.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Bone Disease
    • 8.8.1 Overview
    • 8.8.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Others
    • 8.9.1 Overview
    • 8.9.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biopharmaceutical Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organization (CRO)
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Contract Development and Manufacturing Organization (CDMO)
    • 9.5.1 Overview
    • 9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Bioanalytical Testing Services Market - Country Analysis

  • 10.1 South & Central America Bioanalytical Testing Services Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
      • 10.1.1.1 South & Central America Bioanalytical Testing Services Market by Country
      • 10.1.1.2 Brazil
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 Brazil Bioanalytical Testing Services Market, by Services
        • 10.1.1.2.3.1 Brazil Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.2.4 Brazil Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.2.5 Brazil Bioanalytical Testing Services Market, by End User
      • 10.1.1.3 Argentina
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Argentina Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 Argentina Bioanalytical Testing Services Market, by Services
        • 10.1.1.3.3.1 Argentina Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.3.4 Argentina Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.3.5 Argentina Bioanalytical Testing Services Market, by End User
      • 10.1.1.4 Rest of South & Central America
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Rest of South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 Rest of South & Central America Bioanalytical Testing Services Market, by Services
        • 10.1.1.4.3.1 Rest of South & Central America Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.4.4 Rest of South & Central America Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.4.5 Rest of South & Central America Bioanalytical Testing Services Market, by End User

11. Bioanalytical Testing Services Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Bioanalytical Testing Services Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 SGS SA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Pharmaron Beijing Co Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Element Materials Technology Group Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Charles River Laboratories International Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Eurofins Scientific SE
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Labcorp Drug Development Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Syneos Health Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 ICON Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Intertek Group Plc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. South & Central America Bioanalytical Testing Services Market Segmentation
  • Table 2. Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) - Services
  • Table 3. Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 4. Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 5. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 6. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 7. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 8. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 9. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 10. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 11. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 12. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 13. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 14. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 15. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 16. Glossary of Terms, South & Central America Bioanalytical Testing Services Market

List Of Figures

  • Figure 1. South & Central America Bioanalytical Testing Services Market Segmentation, By Country
  • Figure 2. South & Central America - PEST Analysis
  • Figure 3. South & Central America Bioanalytical Testing Services Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. South & Central America Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. South & Central America Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • Figure 7. Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. South & Central America Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • Figure 16. Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. South & Central America Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 24. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. South & Central America Bioanalytical Testing Services Market, By Country, 2022 ($Mn)
  • Figure 29. South & Central America Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 30. Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Argentina Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 33. Growth Strategies in the Bioanalytical Testing Services Market